Single-Use Bioprocessing

Single-Use Bioprocessing

Global Single-Use Bioprocessing Market to Reach US$80.8 Billion by 2030

The global market for Single-Use Bioprocessing estimated at US$21.5 Billion in the year 2023, is expected to reach US$80.8 Billion by 2030, growing at a CAGR of 20.8% over the analysis period 2023-2030. Single-Use Media Bags & Containers, one of the segments analyzed in the report, is expected to record a 22.6% CAGR and reach US$29.9 Billion by the end of the analysis period. Growth in the Single-Use Assemblies segment is estimated at 21.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.8 Billion While China is Forecast to Grow at 19.3% CAGR

The Single-Use Bioprocessing market in the U.S. is estimated at US$5.8 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.9 Billion by the year 2030 trailing a CAGR of 19.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 19.2% and 17.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.7% CAGR.

Global Single-Use Bioprocessing Market - Key Trends and Drivers Summarized

Why Is Single-Use Bioprocessing Gaining Momentum in the Biopharmaceutical Industry?
Single-use bioprocessing is gaining momentum in the biopharmaceutical industry due to its cost-effectiveness, flexibility, and scalability, which are crucial for meeting the growing demand for biologics, vaccines, and cell and gene therapies. Unlike traditional stainless-steel bioprocessing systems, single-use systems (SUS) use disposable components such as bags, tubing, connectors, and filters, which significantly reduce the risk of cross-contamination, cleaning validation, and downtime. This flexibility is particularly beneficial for small-scale and multi-product manufacturing facilities, where quick changeovers, faster turnaround times, and lower capital investment are key advantages. As biopharma companies increasingly seek efficient and agile production solutions to accelerate time to market, single-use bioprocessing is becoming a preferred choice across upstream, downstream, and fill-finish operations.

How Are Technological Advancements Driving Innovation in Single-Use Bioprocessing?
Technological advancements are driving innovation in single-use bioprocessing by improving the performance, reliability, and integration of single-use systems. The development of high-efficiency, automated, and scalable single-use bioreactors, mixers, and filtration systems is enabling more robust and consistent biomanufacturing processes. Innovations in disposable sensors, connectors, and assemblies are enhancing process monitoring, control, and data integrity, making single-use bioprocessing more efficient and user-friendly. The integration of single-use systems with continuous bioprocessing, modular facilities, and digital solutions is further optimizing biomanufacturing by reducing costs, improving yield, and ensuring regulatory compliance. These advancements are not only enhancing the capabilities of single-use bioprocessing but also addressing the challenges related to scale-up, leachables, extractables, and waste management.

Which Market Segments Are Leading the Adoption of Single-Use Bioprocessing?
Products include single-use bioreactors, filtration assemblies, mixers, bags, tubing, and sensors, with single-use bioreactors being one of the most widely used due to their ability to provide efficient and flexible biomanufacturing solutions. Applications of single-use bioprocessing span monoclonal antibody production, vaccine production, cell and gene therapy, and biosimilars, with monoclonal antibody production leading the market due to the high demand for biologics. End-users include biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and academic and research institutions, with biopharmaceutical companies being the primary adopters due to their focus on cost-effective and scalable production processes. Geographically, North America and Europe are the largest markets for single-use bioprocessing due to strong biopharma infrastructure, technological advancements, and regulatory support, while Asia-Pacific is emerging as a high-growth region driven by expanding biopharma capacity and increasing investments in biologics.

What Are the Key Drivers of Growth in the Single-Use Bioprocessing Market?
The growth in the single-use bioprocessing market is driven by several factors, including the rising demand for flexible, scalable, and cost-effective biomanufacturing solutions, technological advancements in high-efficiency and automated single-use systems, and the increasing use of single-use technologies in monoclonal antibody production, vaccine development, and cell and gene therapy. The development of customizable, integrated, and modular single-use bioprocessing platforms is driving market adoption among biopharmaceutical companies, CDMOs, and academic institutions. The focus on reducing cross-contamination, cleaning validation, and downtime is expanding the market reach among multi-product, small-scale, and flexible manufacturing facilities. The growing use of single-use systems in upstream, downstream, and fill-finish operations, coupled with the demand for eco-friendly, recyclable, and sustainable solutions, is creating new opportunities for market growth. Additionally, the increasing investments in R&D for innovative, disposable sensors, connectors, and assemblies are further supporting market expansion.

Select Competitors (Total 47 Featured) -

• 3M Company
• Applikon Biotechnology BV
• Cesco Bioengineering Co. Ltd.
• Danaher Corporation
• Eppendorf AG
• GE Healthcare
• Thermo Fisher Scientific, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.